| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.05B | +2.0% |
| Gross profit | ¥0.03B | — |
| Operating income | ¥-0.03B | — |
| Net income | ¥-0.03B | — |
| Gross margin | 62.2% | Net margin -50.9% |
| Revenue Q/Q | -82.2% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.02B | 37.8% |
| R&D | ¥0.03B | 58.6% |
| SG&A | ¥0.04B | 70.9% |
| Tax & other | ¥-0.00B | -0.1% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
天山生物 ・ 戴维医疗 ・ 掌趣科技 ・ 珈伟新能 ・ 博晖创新 ・ 麦捷科技 ・ 海达股份 ・ 同大股份 ・ 硕贝德 ・ 华灿光电 ・ 旋极信息 ・ ST凯利
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies